Observational studyArthritis & rheumatology (Hoboken, N.J.)2022

Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.

Alessandra Bettiol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.